Swiss 'shock and horror' sparks currency war

A new currency war looms over markets in the wake of the Swiss National bank's shock decision to unpeg its currency from the euro.

Switzerland has a reputation for being safe and dull. Not now at least as far as investors go. Last Thursday, the Swiss central bank the Swiss National Bank (SNB) caused "a degree of shock and an equal amount of horror", as one banker puts it in the Financial Times. It ditched its efforts to keep the euro from weakening to below SFr1.20.

The franc jumped by more than 30% against the euro in minutes, a "terrifying swing for an established Western currency", says Allister Heath in The Daily Telegraph: they rarely move by more than 2%-3% a day.

It ended the day around 14% stronger, trading at near parity (one for one) with the euro, as the below chart shows. Swiss stocks dived 13%, with exporters leading. "Many fortunes were lost."

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

From Russian oligarchs financing chalets to "average eastern Europeans, who took out mortgages in Swiss francs", investors had amassed huge bets on the Swiss exchange rate staying put, says Randall Forsyth in Barron's.

Some were carry traders, borrowing at rock-bottom interest rates in francs to buy higher-yielding assets elsewhere. Speculators who had borrowed heavily to back their bets lost their shirts. That hit brokers hard, such as Britain's Alpari.

Why now?


The Swiss, like the Germans, are "viscerally attached to the notion of a healthy' currency secure from perceived debasement risks", says Gavekal Dragonomics. The country recently held a referendum on forcing the central bank to own more gold. It failed, but that it occurred at all is telling.

Moreover, the value of the SNB's balance sheet has rocketed to 75% of GDP, "a ratio dwarfing that in other economies engaged in unconventional monetary stimulus", says the FT. SNB fears about European Central Bank (ECB) quantitative easing (QE) forcing more euros into Switzerland must have played a part too.

As the franc shot up, the SNB made losses on its euro holdings, but these might have been even worse later if ECB QE sent the euro plunging. "Already in a hole, the SNB may have decided to stop digging," said The Economist's Buttonwood blog.

What next?

Meanwhile, other central banks with exchange-rate targets have been forced to act too. Denmark, another safe haven with a euro peg, trimmed its key lending and bank deposit rates to eurozone levels. It probably won't stop there. The currency wars have moved to Europe.

The return to gold

Mounting expectations of European Central Bank quantitative easing (QE) have made gold "attractive as a hedge against a debasement of the currency", says Mitsubishi's Jonathan Butler it's already at a near-two-year high of €1,100 an ounce in euros.


But don't get "carried away", warns Capital Economics. A return of global risk appetite aided by QE or a stabilising oil price would temper safe-haven flows, while US rates are still due to rise. Still, they are unlikely to rise fast and global bond yields should remain low amid growth and deflation fears. Demand from emerging-market central banks and consumers is rising. So there is scope, says Capital, for gold to hit $1,400 by year end.

Andrew Van Sickle

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.